L-Fucose | m-entrepreneurship.com

Product Name :
L-Fucose

Search keywords :
(-)-Fucose

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Glycosylation inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ichorion Therapeutics Llc

Active Company_Name :
AUG Therapeutics LLC

Active Indication_Name:
Leukocyte-Adhesion Deficiency Syndrome

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Crenezumab Technical Information
ATG10 Antibody References
Cdk4 Antibody: Cdk4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Cdk4. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts